BC Week In Review | Jan 7, 2013
Clinical News

Augment Chronic Tendinopathy: Phase II started

BioMimetic began a double-blind, placebo-controlled, U.S. Phase II trial to evaluate single injections of 0.45, 0.75, 1.5 and 3 mg Augment Chronic Tendinopathy into the extensor carpi radialis brevis in up to 100 patients. Orthopedic...
Items per page:
1 - 1 of 1